DA
ELV icon

Detalus Advisors’s Elevance Health ELV Stock Holding History

Detalus Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$655K Buy
1,694
+1
+0.1% +$371 0.13% 79
2026
Q1 		$496K Buy
1,693
+1
+0.1% +$329 0.11% 97
2025
Q4 		$593K Sell
1,692
-34
-2% -$11.5K 0.14% 80
2025
Q3 		$558K Buy
1,726
+31
+2% +$9.64K 0.14% 78
2025
Q2 		$659K Hold
1,695
– – 0.19% 68
2025
Q1 		$737K Hold
1,695
– – 0.23% 61
2024
Q4 		$625K Sell
1,695
-112
-6% -$46.9K 0.21% 66
2024
Q3 		$940K Hold
1,807
– – 0.31% 44
2024
Q2 		$979K Buy
1,807
+154
+9% +$81.4K 0.34% 45
2024
Q1 		$857K Hold
1,653
– – 0.31% 46
2023
Q4 		$780K Buy
1,653
+36
+2% +$16.6K 0.31% 49
2023
Q3 		$704K Buy
1,617
+4
+0.2% +$1.81K 0.33% 56
2023
Q2 		$717K Buy
1,613
+45
+3% +$20.8K 0.32% 54
2023
Q1 		$721K Buy
+1,568
New +$746K 0.34% 54

Other funds holding ELV

AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
FI
Focused Investors Los Angeles, California $2.96B AUM 15.6% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Detalus Advisors's ELV Position: Q2 2026 in Review

Detalus Advisors increased its Elevance Health (ELV) stake by 0.06% in Q2 2026, buying an estimated $371 and bringing the position to 1,694 shares worth $655K. The position accounts for 0.13% of the portfolio, ranked #79.

Detalus Advisors first reported a position in ELV in Q1 2023 and has held it in 14 quarters since. The position peaked at $979K in Q2 2024. 601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Detalus Advisors held 1,694 shares of Elevance Health worth $655K as of Q2 2026.
  • Detalus Advisors bought 1 Elevance Health share in Q2 2026, an estimated $371.
  • Elevance Health made up 0.13% of Detalus Advisors's portfolio in Q2 2026, its #79 holding.
  • Detalus Advisors first reported a position in Elevance Health in Q1 2023 and has held it in 14 quarters since.
  • Detalus Advisors's Elevance Health position peaked at $979K in Q2 2024.
  • 601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Detalus Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.